Get all your news in one place.
100's of premium titles.
One app.
Start reading
MarketBeat
MarketBeat
Jessica Mitacek

The FTC Is Suing Hims & Hers Health—Here's Why Investors Shouldn't Panic

As the rotation out of high-flying tech stocks continues, the healthcare sector has been a major beneficiary. Over the past three months, that corner of the market has been one of the strongest performers among the S&P 500’s 11 sectors with a nearly 12% gain.

Hims & Hers Health (NYSE: HIMS), the telehealth platform that provides direct-to-consumer (D2C) personal care products and virtual medical services, has played a role in that rally. Since May 5, shares are up more than 22%.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.